Driedger MR, Cleary SP, Nagorney DM. Synchronous colorectal liver metastases: therapeutic considerations. Hepatobiliary Surg Nutr. 2021;10(5):71113–713.

Article  Google Scholar 

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, et al. Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? Surgery. 2018;163(6):1238–44.

Article  PubMed  Google Scholar 

Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol Off J Eur Soc Med Oncol. 2016;27(8):1386–422.

Article  Google Scholar 

Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D’Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25(29):4575–80. https://doi.org/10.1200/JCO.2007.11.0833.

Article  PubMed  Google Scholar 

Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CWD, Aloia TA, et al. Conditional recurrence-free survival after resection of colorectal liver metastases: persistent deleterious association with RAS and TP53 co-mutation. J Am Coll Surg. 2019;229(3):286-294.e1.

Article  PubMed  PubMed Central  Google Scholar 

Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg. 2001;181(2):153–9.

Article  CAS  PubMed  Google Scholar 

D’Angelica M, Kornprat P, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, et al. Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol. 2011;18(4):1096–103.

Article  PubMed  Google Scholar 

Hill CRS, Chagpar RB, Callender GG, Brown RE, Gilbert JE, Martin RCG, et al. recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol. 2012;19(1):139–44.

Article  PubMed  Google Scholar 

Russolillo N, Sperti E, Langella S, Menonna F, Allieta A, Di Maio M, et al. Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer. HPB. 2020;22(1):116–23.

Article  PubMed  Google Scholar 

Dupré A, Malik HZ, Jones RP, Diaz-Nieto R, Fenwick SW, Poston GJ. Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2018;44(1):80–6.

Google Scholar 

Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46(10 Suppl):S22-31.

PubMed  Google Scholar 

John SKP, Robinson SM, Rehman S, Harrison B, Vallance A, French JJ, et al. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. Dig Surg. 2013;30(4–6):293–301.

Article  CAS  PubMed  Google Scholar 

Sonbol MB, Siddiqi R, Uson PLS, Pathak S, Firwana B, Botrus G, Almader-Douglas D, Ahn DH, Borad MJ, Starr J, Jones J, Stucky CC, Smoot R, Riaz IB, Bekaii-Saab T. The role of systemic therapy in resectable colorectal liver metastases: systematic review and network meta-analysis. Oncologist. 2022;27(12):1034–40. https://doi.org/10.1093/oncolo/oyac212.

Article  PubMed  PubMed Central  Google Scholar 

Filoni E, Musci V, Di Rito A, Inchingolo R, Memeo R, Mannavola F. Multimodal management of colorectal liver metastases: state of the art. Oncol Rev [Internet]. 2024;17. Available from: https://doi.org/10.3389/or.2023.11799.

De Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg. 2009;250(3):440–8.

Article  PubMed  Google Scholar 

Patel RK, Rahman S, Schwantes IR, Bartlett A, Eil R, Farsad K, Fowler K, Goodyear SM, Hansen L, Kardosh A, Nabavizadeh N, Rocha FG, Tsikitis VL, Wong MH, Mayo SC. Updated management of colorectal cancer liver metastases: scientific advances driving modern therapeutic innovations. Cell Mol Gastroenterol Hepatol. 2023;16(6):881–94. https://doi.org/10.1016/j.jcmgh.2023.08.012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garajova I, Balsano R, Tommasi C, Dalla Valle R, Pedrazzi G, Ravaioli M, Spallanzani A, Leonardi F, Santini C, Caputo F, Riefolo M, Giuffrida M, Gelsomino F. Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection. Acta Biomed. 2020;92(1):e2021061. https://doi.org/10.23750/abm.v92i1.11050.

Article  PubMed  PubMed Central  Google Scholar 

National Comprehensive Cancer Network. NCCN Guidelines to Rectal cancer. https://www.nccn.org/professionals/physician_gls/pdf/rectal_blocks.pdf. Accessed 13 Apr 2024.

National Comprehensive Cancer Network. NCCN guidelines to Colon Cancer. https://www.nccn.org/professionals/physician_gls/pdf/colon_blocks.pdf. Accessed 13 Apr 2024.

Andreou A, Knitter S, Schmelzle M, Kradolfer D, Maurer MH, Auer TA, et al. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival. Surgery. 2021;169(5):1061–8.

Article  PubMed  Google Scholar 

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.

Article  Google Scholar 

Symeonidis D, Tepetes K, Tzovaras G, Kissa L, Samara AA, Bompou E, et al. Colorectal cancer liver metastases: is an R1 hepatic resection accepted? Clin Pract. 2022;12(6):1102–10.

Article  PubMed  PubMed Central  Google Scholar 

The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis. J Surg Oncol. 2021;124(4):619–26. https://doi.org/10.1002/jso.26557.

Sakamoto K, Beppu T, Ogawa K, Tamura K, Honjo M, Funamizu N, et al. Prognostic impact of surgical margin width in hepatectomy for colorectal liver metastasis. J Clin Transl Hepatol. 2023;11(3):705–17.

PubMed  PubMed Central  Google Scholar 

Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007–16. https://doi.org/10.1016/S0140-6736(08)60455-9.

Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg. 2012;255(3):534–9. https://doi.org/10.1097/SLA.0b013e3182456aa2.

Buisman FE, Galjart B, van der Stok EP, Balachandran VP, Boerner T, Drebin JA, et al. Recurrence patterns after resection of colorectal liver metastasis are modified by perioperative systemic chemotherapy. World J Surg. 2020;44(3):876–86.

Article  PubMed  PubMed Central  Google Scholar 

Kobayashi K, Ono Y, Kitano Y, Oba A, Sato T, Ito H, et al. Prognostic impact of tumor markers (CEA and CA19-9) on patients with resectable colorectal liver metastases stratified by tumor number and size: potentially valuable biologic markers for preoperative treatment. Ann Surg Oncol. 2023;30(12):7338–47.

Article  PubMed  Google Scholar 

Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, Ohue M, Komori K, Shiomi A, Shiozawa M, Watanabe J, Suto T, Kinugasa Y, Takii Y, Bando H, Kobatake T, Inomata M, Shimada Y, Katayama H, Fukuda H, JCOG Colorectal Cancer Study Group. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789–99. https://doi.org/10.1200/JCO.21.01032.

Article  CAS  PubMed  Google Scholar 

Saude Conde R, Bregni G, Saad E, Hendlisz A, Sclafani F. JCOG0603: are we really sure this was a negative trial? J Clin Oncol. 2022;40(7):803–5. https://doi.org/10.1200/JCO.21.02299.

Article  PubMed  Google Scholar 

Matias M, Casa-Nova M, Faria M, Pires R, Tato-Costa J, Ribeiro L, et al. Prognostic factors after liver resection for colorectal liver metastasis. Acta Med Port. 2015;28(3):357–69.

Article  CAS  PubMed  Google Scholar 

Takeda Y, Mise Y, Takahashi Y, Ito H, Inoue Y, Yoshioka R, et al. Limited prognostic value of KRAS in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2022;29(4):2383–91.

Article  PubMed  Google Scholar 

Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, et al. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105(9):1210–20.

Article  CAS  PubMed  Google Scholar 

Kawaguchi Y, Kopetz S, Cao HST, Panettieri E, Bellis MD, Nishioka Y, et al. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. 2021;108(8):968.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hadden WJ, de Reuver PR, Brown K, Mittal A, Samra JS, Hugh TJ. Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes. HPB. 2016;18(3):209–20.

Article  PubMed  PubMed Central